相关实验视频

Updated: Jun 25, 2026

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

无转基因的直接转化,将小鼠纤维细胞转化为功能肌肉干细胞

Xhem Qabrati¹, Inseon Kim¹, Adhideb Ghosh^1,2

¹Laboratory of Regenerative and Movement Biology, Department of Health Sciences and Technology, ETH Zurich, Schwerzenbach, Switzerland.

NPJ Regenerative medicine

|August 8, 2023

概括

这项研究提出了一种新的,更安全的细胞重编程方法,使用合成mRNA和小分子来创建肌源性原生细胞. 这些细胞在杜氏肌肉衰竭模型中有效地再生肌肉组织.

科学领域:

细胞重新编程的细胞重编程.
再生医学是一种再生医学.
分子生物学分子生物学

背景情况:

病毒载体通常用于细胞重编程,但具有基因组整合的风险.
开发更安全,无转基因的方法对于再生医学的临床应用至关重要.

研究的目的:

开发一种高效的,无转基因的方法,将纤维细胞转化为诱导肌原性原生细胞 (iMPC).
利用合成的MyoD-mRNA和一个小分子尾酒来增强纤维细胞重编程.
评估iMPCs在肌肉再生方面的潜力.

主要方法:

选候选化合物以识别抑制JNK和JAK/STAT通路的分子.
为短暂的合成MyoD-mRNA过度表达开发一个最佳的转染协议.
使用转录组测试来分析重编程期间的基因表达变化.

主要成果:

在10天内实现了强大的纤维细胞重编程到Pax7阳性iMPCs.
在体外证明iMPCs的广泛扩散和分化成髓管.
在类似于卫星细胞的iMPC中确定了Pax7+干细胞亚群.
在杜申肌肉发育不良症小鼠模型中展示了IMPCs的成功移植,恢复了发育不良的表达.

结论:

开发的无转基因方法为产生肌性干细胞提供了临床上更安全的替代方案.
这些iMPC显示出在体内有效的肌肉再生的潜力.
这种方法通过克服基于病毒载体的重编程的局限性,推动了再生医学领域的发展.

更多相关视频

Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling

Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling

Published on: January 18, 2015

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

相关概念视频

Transgenic Organisms

Transgenic Organisms

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...